Juan Luis
Delgado Marin
Asociado Ciencias de la Salud
Homerton University Hospital
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de Homerton University Hospital (7)
2022
-
STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35–37 weeks' gestation
Ultrasound in Obstetrics and Gynecology, Vol. 59, Núm. 1, pp. 69-75
2021
-
Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial
Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 257-265
2018
-
ASPRE Trial: Incidence of Preterm Preeclampsia in Patients Fulfilling ACOG and NICE Criteria According to Risk by FMF Algorithm
Obstetrical and Gynecological Survey, Vol. 73, Núm. 11, pp. 623-625
-
ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm
Ultrasound in Obstetrics and Gynecology, Vol. 51, Núm. 6, pp. 738-742
-
Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation
Ultrasound in Obstetrics and Gynecology, Vol. 52, Núm. 2, pp. 186-195
2017
-
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history
American Journal of Obstetrics and Gynecology, Vol. 217, Núm. 5, pp. 585.e1-585.e5
-
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia
American Journal of Obstetrics and Gynecology, Vol. 217, Núm. 6, pp. 685.e1-685.e5